Financial Ratios | Torrent Pharmaceuticals Ltd. | R Wadiwala Securities Pvt Ltd

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE2626.40-0.7 (-0.03 %)
PREV CLOSE (Rs.) 2627.10
OPEN PRICE (Rs.) 2627.60
BID PRICE (QTY) 2623.25 (11)
OFFER PRICE (QTY) 2626.60 (14)
VOLUME 2025
TODAY'S LOW / HIGH (Rs.)2614.00 2643.20
52 WK LOW / HIGH (Rs.)1446.15 2699.95
NSE2625.95-1 (-0.04 %)
PREV CLOSE( Rs. ) 2626.95
OPEN PRICE (Rs.) 2626.95
BID PRICE (QTY) 2624.60 (6)
OFFER PRICE (QTY) 2625.95 (8)
VOLUME 35005
TODAY'S LOW / HIGH(Rs.) 2611.95 2643.90
52 WK LOW / HIGH (Rs.)1445.55 2700

Financial Ratios

Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)36.7945.9273.9760.5525.78
   CEPS(Rs)57.6742.5256.4249.6131.14
   DPS(Rs)22.0048.0035.0032.0017.00
   Book NAV/Share(Rs)183.13351.75344.90284.99279.15
   Tax Rate(%)32.5936.6017.9813.6422.32
Margin Ratios
   Core EBITDA Margin(%)17.2715.9816.6714.5113.61
   EBIT Margin(%)13.349.7412.6310.957.33
   Pre Tax Margin(%)11.308.0610.267.943.87
   PAT Margin (%)7.615.118.416.853.00
   Cash Profit Margin (%)11.949.4612.8411.237.26
Performance Ratios
   ROA(%)9.205.929.207.503.15
   ROE(%)20.5013.1823.4921.479.34
   ROCE(%)20.3214.3517.6215.289.75
   Asset Turnover(x)1.211.161.091.091.05
   Sales/Fixed Asset(x)1.391.431.431.481.50
   Working Capital/Sales(x)-122.4220.2823.62-31.47-113.68
Efficiency Ratios
   Fixed Capital/Sales(x)0.720.700.700.680.67
   Receivable days39.9137.8638.9237.6533.78
   Inventory Days52.3661.7159.2449.8449.01
   Payable days243.50306.08383.19381.76370.58
Valuation Parameters
   PER(x)41.7930.4517.1816.2837.86
   PCE(x)26.6632.8822.5219.8731.35
   Price/Book(x)8.407.957.376.926.99
   Yield(%)1.431.721.381.620.87
   EV/Net Sales(x)5.905.995.904.854.99
   EV/Core EBITDA(x)19.6619.3818.6216.8218.75
   EV/EBIT(x)26.0334.4025.1323.5435.91
   EV/CE(x)3.924.043.462.842.78
   M Cap / Sales5.415.565.374.204.31
Growth Ratio
   Net Sales Growth(%)13.076.290.823.4728.96
   Core EBITDA Growth(%)9.873.5810.7112.3323.79
   EBIT Growth(%)47.24-21.1914.7853.68-14.04
   PAT Growth(%)60.22-37.9222.17134.86-35.66
   EPS Growth(%)-19.88-37.9222.17134.88-35.66
Financial Stability Ratios
   Total Debt/Equity(x)0.850.680.831.211.28
   Current Ratio(x)0.981.171.130.910.98
   Quick Ratio(x)0.570.620.590.520.60
   Interest Cover(x)6.545.815.323.632.11
   Total Debt/Mcap(x)0.100.080.110.180.18